Home » Topics » BioWorld Science

BioWorld Science
RSS

EMA committee backs approval of trastuzumab biosimilar Trazimera

June 4, 2018

EMA committee recommends approval of Translarna for younger children with DMD

June 4, 2018

First phase I data presented for LOXO-292 in RET-altered cancers

June 4, 2018

Novartis completes divestment of joint venture to GSK

June 4, 2018

FDA approves Consensi for osteoarthritis pain and hypertension

June 4, 2018

EMA CHMP recommends approval of Sandoz adalimumab biosimilar

June 4, 2018

Taiwan Liposome submits IND for phase I/II trial of TLC-178 in pediatric rhabdomyosarcoma

June 4, 2018

FDA approves Olumiant 2 mg for moderate to severe rheumatoid arthritis

June 4, 2018

U.S. orphan designation granted to Alnylam Pharmaceuticals siRNA therapy for amyloidosis

June 4, 2018

Fully human antibody cocktail shows postexposure protection against lethal Ebola virus in primates

June 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...